1. Academic Validation
  2. Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery

Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery

  • J Med Chem. 2022 Oct 27;65(20):13483-13504. doi: 10.1021/acs.jmedchem.2c00969.
Timothy B Callis 1 Taylor R Garrett 1 Andrew P Montgomery 1 Jonathan J Danon 1 Michael Kassiou 1
Affiliations

Affiliation

  • 1 School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
Abstract

The concept of bioisosterism and the implementation of bioisosteric replacement is fundamental to medicinal chemistry. The exploration of bioisosteres is often used to probe key structural features of candidate pharmacophores and enhance pharmacokinetic properties. As the understanding of bioisosterism has evolved, capabilities to undertake more ambitious bioisosteric replacements have emerged. Scaffold hopping is a broadly used term in the literature referring to a variety of different bioisosteric replacement strategies, ranging from simple heterocyclic replacements to topological structural overhauls. In this work, we have highlighted recent applications of scaffold hopping in the central nervous system drug discovery space. While we have highlighted the benefits of using scaffold hopping approaches in central nervous system drug discovery, these are also widely applicable to Other medicinal chemistry fields. We also recommend a shift toward the use of more refined and meaningful terminology within the realm of scaffold hopping.

Figures